Jamie Bizzell, MD
Otolaryngology · Little Rock, ARNPI 1447593371
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 38.9% of the total. 2025 is the largest year on record at $233, 7.6 times the $31 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in AR, where the typical reported total is $742.
Across 24 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$219
- GSK$159
- Stryker$68
- Neurent Medical Limited$51
- Aerin Medical Inc.$47
- Optinose US, Inc.$19
What the payments were for
- Food & beverage$563100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $219 |
| GSK | 9 | $159 |
| Stryker | 3 | $68 |
| Neurent Medical Limited | 1 | $51 |
| Aerin Medical Inc. | 1 | $47 |
| Optinose US, Inc. | 1 | $19 |
How this compares
$563 in reported general payments places this provider in the 40th percentile of 72 otolaryngology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 158 | $3,425 |
| Fluticasone Propionate | 171 | $1,807 |
| Ipratropium Bromide | 30 | $925 |
| Gabapentin | 55 | $556 |
| Omeprazole | 60 | $535 |
| Famotidine | 42 | $433 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $291 |
| Doxycycline Hyclate | 14 | $194 |
| Mometasone Furoate | 11 | $132 |
| Pantoprazole Sodium | 20 | $116 |
| Mupirocin | 11 | $65 |
| Levocetirizine Dihydrochloride | 20 | $41 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Little Rock
- Ozlem Tulunay UgurLittle Rock$3K
- James RussellLittle Rock$3K
- Larry HartzellLittle Rock$2K
- Julie HighlandLittle Rock$1K
- Chrystal Lau-StoneLittle Rock$837
- Jumin SundeLittle Rock$742
- Joe ColclasureLittle Rock$642
- John SimsLittle Rock$604
- Scott SternLittle Rock$600
- William RolstonLittle Rock$594
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.